CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
CNBX Pharmaceuticals Enterprise Value : 1.305M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.305M |
| October 22, 2026 | 1.305M |
| October 21, 2026 | 1.305M |
| October 20, 2026 | 1.305M |
| October 19, 2026 | 1.379M |
| October 16, 2026 | 1.379M |
| October 15, 2026 | 1.357M |
| October 14, 2026 | 1.379M |
| October 13, 2026 | 1.453M |
| October 12, 2026 | 1.453M |
| October 09, 2026 | 1.453M |
| October 08, 2026 | 1.453M |
| October 07, 2026 | 1.394M |
| October 06, 2026 | 1.453M |
| October 05, 2026 | 1.305M |
| October 02, 2026 | 1.305M |
| October 01, 2026 | 1.305M |
| September 30, 2026 | 1.305M |
| September 29, 2026 | 1.379M |
| September 28, 2026 | 1.305M |
| September 25, 2026 | 1.305M |
| September 24, 2026 | 1.305M |
| September 23, 2026 | 1.305M |
| September 22, 2026 | 1.453M |
| September 21, 2026 | 1.305M |
| Date | Value |
|---|---|
| September 18, 2026 | 1.313M |
| September 17, 2026 | 1.305M |
| September 16, 2026 | 1.305M |
| September 15, 2026 | 1.305M |
| September 14, 2026 | 1.305M |
| September 11, 2026 | 1.305M |
| September 10, 2026 | 1.305M |
| September 09, 2026 | 1.159M |
| September 08, 2026 | 1.305M |
| September 04, 2026 | 1.305M |
| September 03, 2026 | 1.453M |
| September 02, 2026 | 1.305M |
| September 01, 2026 | 1.379M |
| August 31, 2026 | 1.364M |
| August 28, 2026 | 1.364M |
| August 27, 2026 | 1.364M |
| August 26, 2026 | 1.453M |
| August 25, 2026 | 1.379M |
| August 24, 2026 | 1.379M |
| August 21, 2026 | 1.379M |
| August 20, 2026 | 1.453M |
| August 19, 2026 | 1.305M |
| August 18, 2026 | 1.305M |
| August 17, 2026 | 1.305M |
| August 14, 2026 | 1.379M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 12.20M |
| Arvinas, Inc. | -83.01M |
| Fulcrum Therapeutics, Inc. | -32.83M |
| Definium Therapeutics, Inc. | 3.745B |
| LeonaBio, Inc. | -4.889M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1542M |
| Total Expenses (Quarterly) | 0.1542M |
| EPS Diluted (Quarterly) | -0.0001 |
| Earnings Yield | -600.0% |
| Normalized Earnings Yield | -600.00 |